Immunosuppression in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma
Status:
Completed
Trial end date:
2014-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and efficacy of sirolimus-based
immunosuppressive therapy in patients following orthotopic liver transplantation (OLT) for
hepatocellular carcinoma (HCC), with regard to HCC recurrence-free patient survival.